Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic.

Autor: van Lierop ZY; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Wessels MH; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Lekranty WM; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Moraal B; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Hof SN; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Hogenboom L; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., de Jong BA; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Meijs N; Department of Neurology, Zuyderland Hospital, Sittard-Geleen, The Netherlands., Mensing LA; Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands., van Oosten BW; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Sol N; Department of Neuro-Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Kempen ZL; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Vermunt L; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Willems MJ; Department of Neurology, Diakonessenhuis, Utrecht, The Netherlands., Strijbis EM; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Uitdehaag BM; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Killestein J; Department of Neurology, Amsterdam UMC (Location VUmc), Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Nov; Vol. 30 (13), pp. 1620-1629. Date of Electronic Publication: 2024 Oct 17.

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.

Autor: Wessels MH, Van Lierop ZY; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Noteboom S; Department of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Strijbis EM; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Heijst JA; Department of Clinical Chemistry, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Van Kempen ZL; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Moraal B; Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Barkhof F; Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Queen Square Institute of Neurology, Centre for Medical Image Computing, University College London, London, UK., Uitdehaag BM; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Schoonheim MM; Department of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Killestein J; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Teunissen CE; Department of Clinical Chemistry, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Sep; Vol. 29 (10), pp. 1229-1239. Date of Electronic Publication: 2023 Aug 02.

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.

Autor: van Lierop ZY; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Toorop AA; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van Ballegoij WJ; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands/Department of Neurology, OLVG Hospital, Amsterdam, The Netherlands., Olde Dubbelink TB; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands/Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Strijbis EM; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Jong BA; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van Oosten BW; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Moraal B; Department of Radiology & Nuclear Medicine, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Teunissen CE; Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Uitdehaag BM; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Killestein J; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kempen ZLV; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2022 Jun; Vol. 28 (7), pp. 1121-1125. Date of Electronic Publication: 2021 Jul 09.

Long-Term Follow Up in Anti-Contactin-1 Autoimmune Nodopathy.

Autor: Caballero-Ávila M; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Martín-Aguilar L; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Pascual-Goñi E; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Michael MR; Department of Neurology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Koel-Simmelink MJA; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam UMC, Amsterdam, the Netherlands., Höftberger R; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria., Wanschitz J; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Alonso-Jiménez A; Department of Neurology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium., Armangué T; Neuroimmunology program, IDIBAPS-Hospital de Clinic; University of Barcelona. Pediatric Neuroimmunology Program, Neurology Department, Sant Joan de Deu Children's Hospital, Barcelona, Spain., Baars AE; Department of Neurology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., Carbayo Á; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Castek B; Department of Neurology, Landeskrankenhaus Villach, Villach, Austria., Collet-Vidiella R; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., De Winter J; Department of Neurology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium., Del Real MÁ; Department of Neurology, General University Hospital of Ciudad Real, Ciudad Real, Spain., Delmont E; Referral Centre for Neuromuscular Diseases and ALS, Hospital La Timone, Marseille, France., Diamanti L; IRCCS Mondino Foundation, Pavia, Italy., Doneddu PE; Neuromuscular and Neuroimmunology Unit, IRCCS Humanitas Research Hospital, Rozzano, Department of Biomedical Sciences, Humanitas University, Milan, Italy., Hiew FL; Department of Neurology, Sunway Medical Center, Bandar Sunway, Malaysia., Gallardo E; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Neuromuscular Diseases, Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain., Gonzalez A; Department of Neurology, University Hospital Cruces, Barakaldo, Spain., Grinzinger S; Department of Neurology, Christian-Doppler Klinik, Salzburg, Austria., Horga A; Department of Neurology, Neuromuscular Diseases Unit, University Hospital San Carlos, Madrid, Spain., Iglseder S; Department of Neurology, Krankenhaus Barmherzige Brüder, Linz, Austria., Jacobs BC; Department of Neurology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., Jauregui A; Department of Neurology, University Hospital Cruces, Barakaldo, Spain., Killestein J; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam UMC, Amsterdam, the Netherlands., Pozza EL; Department of Neurology, Klinik Favoriten, Vienna, Austria., Martínez-Martínez L; Department of Immunology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Nobile-Orazio E; Neuromuscular and Neuroimmunology Unit, IRCCS Humanitas Research Hospital, Rozzano, Department of Medical Biotechnology and Translational Medicine, Milan University, Milan, Italy., Ortiz N; Department of Neurology, University Hospital Sant Joan, Reus, Spain., Pérez-Pérez H; Department of Neurology, University Hospital of Canarias, Tenerife, Spain., Poppert KN; Department of Neurology, Christian-Doppler Klinik, Salzburg, Austria., Ripellino P; Department of Neurology, Neurocenter of Southern Switzerland EOC, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Roche JC; Department of Neurology, University Hospital Miguel Servet, Zaragoza, Spain., Rodriguez de Rivera FJ; Department of Neurology, Instituto de Investigación Sanitaria del Hospital Universitario La Paz-IdiPAZ, University Hospital La Paz, Universidad Autónoma de Madrid, Madrid, Spain., Rostasy K; Department of Pediatric Neurology, Children's Hospital Datteln, Witten/Herdecke University, Datteln, Germany., Sparasci D; Department of Neurology, Neurocenter of Southern Switzerland EOC, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Tejada-Illa C; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Teunissen CCE; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam UMC, Amsterdam, the Netherlands., Vegezzi E; IRCCS Mondino Foundation, Pavia, Italy., Xuclà-Ferrarons T; Department of Neurology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain., Zach F; Department of Neurology, Kardinal Schwarzenberg Klinikum, Salzburg, Austria., Wieske L; Department of Neurology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Eftimov F; Department of Neurology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Lleixà C; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Neuromuscular Diseases, Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain., Querol L; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.; Neuromuscular Diseases, Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.

Publikováno v: Annals of neurology [Ann Neurol] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.

Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis.

Autor: Rodriguez-Mogeda, Carla^1,2,3 (AUTHOR) c.rodriguezmogeda@amsterdamumc.nl, van Lierop, Zoë Y. G. J.^2,3,4 (AUTHOR), van der Pol, Susanne M. A.^1,2,3 (AUTHOR), Coenen, Loet^1,2,5 (AUTHOR), Hogenboom, Laura^2,3,4 (AUTHOR), Kamermans, Alwin^1,2,3 (AUTHOR), Rodriguez, Ernesto^1,6,7 (AUTHOR), van Horssen, Jack^1,2,3 (AUTHOR), van Kempen, Zoé L. E.^2,3,4 (AUTHOR), Uitdehaag, Bernard M. J.^2,3,4 (AUTHOR), Teunissen, Charlotte E.^2,8,9 (AUTHOR), Witte, Maarten E.^1,2,3,7 (AUTHOR), Killestein, Joep^2,3,4 (AUTHOR), de Vries, Helga E.^1,2,3 (AUTHOR)

Publikováno v: Journal of Neuroinflammation. 9/26/2023, Vol. 20 Issue 1, p1-17. 17p.